Anti-T Lymphocyte Globulin (ATLG)(Institute Of Hematology & Blood Diseases Hospital)

N/A

Report date: 2024/08/23 20:00:42

Base Information

Drug NameAnti-T Lymphocyte Globulin (ATLG)(Institute Of Hematology & Blood Diseases Hospital)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAnemia, AplasticHematopoietic stem cell transplantation (HSCT)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesInstitute Of Hematology & Blood Diseases Hospital
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Hematology & Blood Diseases Hospital
Inactive CompaniesN/A
Active IndicationsAnemia, AplasticHematopoietic stem cell transplantation (HSCT)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A